Symbiosis II LLC to sell Clene (NASDAQ: CLNN) shares after recent sales

Rhea-AI Filing Summary

Clene Inc. insider Symbiosis II LLC has filed a notice to sell 60,842 shares of CLNN common stock. The planned sale, through Merrill Lynch on Nasdaq around 01/29/2026, has an aggregate market value of $265,731, compared with 10,333,980 shares outstanding.

The shares were acquired on 06/20/2023 via an open-market purchase for cash. The filing also lists numerous prior open-market sales by Symbiosis II LLC from December 2025 through January 29, 2026, with gross proceeds disclosed for each trade. The seller represents it is not aware of undisclosed material adverse information about Clene.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104	60842	265731	10333980	01/29/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/20/2023	Open Market Purchase	Issuer			60842	06/20/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/03/2025	56577	444427.67
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/04/2025	72748	489587.42
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/05/2025	37235	221036.49
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/08/2025	21463	122370.71
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/09/2025	15031	89499.34
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/10/2025	9921	63700.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/11/2025	10907	74275.63
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/12/2025	7603	51630.22
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/15/2025	10580	68677.41
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/16/2025	7030	44350.71
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/17/2025	2884	19063.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/18/2025	5816	36787.27
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/19/2025	5582	36025.7
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/22/2025	4367	28547.39
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/23/2025	6831	42848.38
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/24/2025	1490	9336.79
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/26/2025	3350	21174.24
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/29/2025	8096	48159.37
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/30/2025	4138	24966.83
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/31/2025	13095	76054.07
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/02/2026	4015	2296.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/05/2026	5869	34472.7
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/06/2026	3111	18791.18
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/07/2026	3938	24771.49
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/08/2026	3195	19448.5
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/09/2026	9075	56900.82
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/12/2026	32705	179867.17
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/13/2026	26105	127631.6
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/14/2026	19621	100496.05
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/15/2026	12563	6404.34
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/16/2026	7923	40626.13
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/20/2026	12432	59731.78
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/21/2026	12119	61227.75
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/22/2026	12665	67323.13
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/23/2026	5556	29256.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/26/2026	6418	32186.97
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/27/2026	4139	21016.06
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/28/2026	8717	42789.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	3810	15843.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	7664	33472.96

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CLNN Form 144 filing by Symbiosis II LLC disclose?

The filing discloses a planned sale of 60,842 Clene (CLNN) common shares. Symbiosis II LLC intends to sell these shares through Merrill Lynch on Nasdaq, with an aggregate market value of $265,731, and confirms it knows no undisclosed material adverse information about Clene.

How many CLNN shares is Symbiosis II LLC planning to sell under this Form 144?

Symbiosis II LLC plans to sell 60,842 CLNN common shares. The notice shows these shares have an aggregate market value of $265,731 and are to be sold on Nasdaq through Merrill Lynch, compared with 10,333,980 Clene shares outstanding.

When and how did Symbiosis II LLC acquire the CLNN shares it now plans to sell?

The shares were acquired on June 20, 2023 via an open-market purchase. The table states Symbiosis II LLC acquired 60,842 Clene common shares from the issuer on 06/20/2023, paying the purchase price in cash on the same date.

What prior CLNN share sales by Symbiosis II LLC are disclosed in this Form 144?

The filing lists numerous prior open-market sales of CLNN shares since December 2025. It details daily transactions by Symbiosis II LLC from 12/03/2025 through 01/29/2026, including the number of common shares sold and gross proceeds for each sale.

What representation does the CLNN Form 144 filer make about inside information?

The filer represents it is not aware of undisclosed material adverse information about Clene. By signing, the person for whose account the securities are sold affirms no knowledge of non-public negative information regarding Clene’s current or prospective operations.

Through which broker and exchange will the CLNN shares be sold under this notice?

The planned CLNN share sale will be executed through Merrill Lynch on Nasdaq. The securities information table identifies Merrill Lynch’s San Francisco office as broker, specifies the common stock class, and names Nasdaq as the securities exchange for the intended transactions.